Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.

Headline

Lack of leadership and clinical skills are a 'barrier' to pharmacy investment, warns NHS England

Comment

Whilst respecting Bruce Warner, Keith Ridge and the team they head I must take issue with the comments about poor take up of clinical leadership and academic courses. It’s surely not yet “old news” that community pharmacists have been working in a severely tightened area since the funding cuts were announced and implemented. The “efficiencies “ demanded of us have meant that more is being done by fewer and time is at a rarified premium. How many companies can invest in the protected learning time and backfill costs required to study and achieve these qualifications for staff when there has been absolutely no discussion of what roles such staff may occupy, what roles will develop and what, (God forbid) will be paid to those undertaking such responsibilities? At last the LTP is announced almost a year after the announcement of the funds for training but the LTP is incredibly light on detail. A proposed new contract has been on the cards for over a year with no discussion or even wish list yet in the public domain ( punishment for having the temerity to seek leave for a judicial review?). Investment requires confidence and the support of a lending organisation. With government policy being pharmacy closures and even PSNC announcing it’s intention to facilitate closures, pharmacies struggling to pay wholesale bills and defaulting on bank commitments, exactly what is the incentive to invest and why should a bank agree? Why is the CPRS not yet a national scheme? Why are CCGs encouraged to scrap minor ailments schemes, Local authorities scrapping EHC and Smoking cessation schemes? How many community pharmacists have completely wasted their time acquiring prescribing qualifications to date? In this climate ( funnily enough not the case in Wales or particularly Scotland which has long encouraged and invested in pharmacies recognising the recruitment crisis in practice nurses and GP doctors) why does anyone expect pharmacy companies to invest in supporting staff to acquire higher qualifications? Give us a steer and start talking about a framework including financial incentive ( you know, like GPs are offered in order to change their practice?) and I guarantee that pharmacy companies will be there. Until then Bruce, please own the vacuum that exists and accept it’s stultifying impact.

Posted date

22 JAN 2019

Posted time

0:23

Mandatory
Mandatory
Mandatory
Headline

Lack of leadership and clinical skills are a 'barrier' to pharmacy investment, warns NHS England

Comment

Whilst respecting Bruce Warner, Keith Ridge and the team they head I must take issue with the comments about poor take up of clinical leadership and academic courses. It’s surely not yet “old news” that community pharmacists have been working in a severely tightened area since the funding cuts were announced and implemented. The “efficiencies “ demanded of us have meant that more is being done by fewer and time is at a rarified premium. How many companies can invest in the protected learning time and backfill costs required to study and achieve these qualifications for staff when there has been absolutely no discussion of what roles such staff may occupy, what roles will develop and what, (God forbid) will be paid to those undertaking such responsibilities? At last the LTP is announced almost a year after the announcement of the funds for training but the LTP is incredibly light on detail. A proposed new contract has been on the cards for over a year with no discussion or even wish list yet in the public domain ( punishment for having the temerity to seek leave for a judicial review?). Investment requires confidence and the support of a lending organisation. With government policy being pharmacy closures and even PSNC announcing it’s intention to facilitate closures, pharmacies struggling to pay wholesale bills and defaulting on bank commitments, exactly what is the incentive to invest and why should a bank agree? Why is the CPRS not yet a national scheme? Why are CCGs encouraged to scrap minor ailments schemes, Local authorities scrapping EHC and Smoking cessation schemes? How many community pharmacists have completely wasted their time acquiring prescribing qualifications to date? In this climate ( funnily enough not the case in Wales or particularly Scotland which has long encouraged and invested in pharmacies recognising the recruitment crisis in practice nurses and GP doctors) why does anyone expect pharmacy companies to invest in supporting staff to acquire higher qualifications? Give us a steer and start talking about a framework including financial incentive ( you know, like GPs are offered in order to change their practice?) and I guarantee that pharmacy companies will be there. Until then Bruce, please own the vacuum that exists and accept it’s stultifying impact.

Posted date

22 JAN 2019

Posted time

0:23

Mandatory
Mandatory
Mandatory
Mandatory

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.